BCLI
BRAINSTORM CELL THERAPUTC
BCLI
BCLI
Delisted
BCLI was delisted on the 17th of July, 2025.
37 hedge funds and large institutions have $9.04M invested in BRAINSTORM CELL THERAPUTC in 2018 Q3 according to their latest regulatory filings, with 4 funds opening new positions, 8 increasing their positions, 7 reducing their positions, and 6 closing their positions.
Holders
37
Holders Change
-2
Holders Change %
-5.13%
% of All Funds
0.85%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
4
Increased
8
Reduced
7
Closed
6
Calls
$65K
Puts
$39K
Net Calls
+$26K
Net Calls Change
-$186K
Top Buyers
Top Sellers
| 1 |
1
Morgan Stanley
New York
|
$37K |
| 2 |
2
JPMorgan Chase & Co
New York
|
$395K |
| 3 |
SM
3
Sabby Management
Miami Beach,
Florida
|
$3.47M |
| 4 |
4
Goldman Sachs
New York
|
$0 |
| 5 |
5
Cerity Partners
New York
|
$0 |
